Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives
Abstract Glioblastoma (GBM) is a highly aggressive adult brain cancer, characterised by poor prognosis and a dismal five-year survival rate. Despite significant knowledge gains in tumour biology, meaningful advances in patient survival remain elusive. The field of neuro-oncology faces many disease o...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2025-01-01
|
| Serie: | Acta Neuropathologica Communications |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s40478-025-01928-x |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|